252 related articles for article (PubMed ID: 19966540)
1. Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.
Chao P; Deshmukh M; Kutscher HL; Gao D; Rajan SS; Hu P; Laskin DL; Stein S; Sinko PJ
Anticancer Drugs; 2010 Jan; 21(1):65-76. PubMed ID: 19966540
[TBL] [Abstract][Full Text] [Related]
2. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker.
Conover CD; Greenwald RB; Pendri A; Gilbert CW; Shum KL
Cancer Chemother Pharmacol; 1998; 42(5):407-14. PubMed ID: 9771956
[TBL] [Abstract][Full Text] [Related]
3. Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.
Zhang F; Zhu G; Jacobson O; Liu Y; Chen K; Yu G; Ni Q; Fan J; Yang Z; Xu F; Fu X; Wang Z; Ma Y; Niu G; Zhao X; Chen X
ACS Nano; 2017 Sep; 11(9):8838-8848. PubMed ID: 28858467
[TBL] [Abstract][Full Text] [Related]
4. Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.
Nguyen F; Guan P; Guerrero DT; Kolla V; Naraparaju K; Perry LM; Soberman D; Pressly BB; Alferiev IS; Chorny M; Brodeur GM
Cancer Res; 2020 Oct; 80(19):4258-4265. PubMed ID: 32839252
[TBL] [Abstract][Full Text] [Related]
5. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D
Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843
[TBL] [Abstract][Full Text] [Related]
6. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy.
He W; Du Y; Zhou W; Wang T; Li M; Li X
Eur J Pharm Sci; 2020 Jul; 150():105340. PubMed ID: 32371069
[TBL] [Abstract][Full Text] [Related]
7. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin.
Tang XJ; Han M; Yang B; Shen YQ; He ZG; Xu DH; Gao JQ
Int J Pharm; 2014 Dec; 477(1-2):536-45. PubMed ID: 25445532
[TBL] [Abstract][Full Text] [Related]
8. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy.
Li Y; Liu R; Yang J; Ma G; Zhang Z; Zhang X
Biomaterials; 2014 Dec; 35(36):9731-45. PubMed ID: 25189519
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
10. A GSH-Responsive Nanoprodrug System Based on Self-Assembly of Lactose Modified Camptothecin for Targeted Drug Delivery and Combination Chemotherapy.
Hou C; Ma N; Shen Z; Chi G; Chao S; Pei Y; Chen L; Lu Y; Pei Z
Int J Nanomedicine; 2020; 15():10417-10424. PubMed ID: 33376329
[TBL] [Abstract][Full Text] [Related]
11. A series of alpha-amino acid ester prodrugs of camptothecin: in vitro hydrolysis and A549 human lung carcinoma cell cytotoxicity.
Deshmukh M; Chao P; Kutscher HL; Gao D; Sinko PJ
J Med Chem; 2010 Feb; 53(3):1038-47. PubMed ID: 20063889
[TBL] [Abstract][Full Text] [Related]
12. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs.
Conover CD; Greenwald RB; Pendri A; Shum KL
Anticancer Drug Des; 1999 Dec; 14(6):499-506. PubMed ID: 10834271
[TBL] [Abstract][Full Text] [Related]
13. Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats.
Kutscher HL; Chao P; Deshmukh M; Singh Y; Hu P; Joseph LB; Reimer DC; Stein S; Laskin DL; Sinko PJ
J Control Release; 2010 Apr; 143(1):31-7. PubMed ID: 20043961
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy.
Ma W; Su H; Cheetham AG; Zhang W; Wang Y; Kan Q; Cui H
J Control Release; 2017 Oct; 263():102-111. PubMed ID: 28082170
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of small interfering RNA using a camptothecin prodrug as the carrier.
Tang Q; Cao B; Cheng G
Chem Commun (Camb); 2014 Feb; 50(11):1323-5. PubMed ID: 24343195
[TBL] [Abstract][Full Text] [Related]
16. Human neural stem cell tropism to metastatic breast cancer.
Zhao D; Najbauer J; Annala AJ; Garcia E; Metz MZ; Gutova M; Polewski MD; Gilchrist M; Glackin CA; Kim SU; Aboody KS
Stem Cells; 2012 Feb; 30(2):314-25. PubMed ID: 22084033
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of water soluble poly(L-glutamic acid)-camptothecin conjugate against resistant human lung cancer xenografted in nude mice.
Zou Y; Wu QP; Tansey W; Chow D; Hung MC; Charnsangavej C; Wallace S; Li C
Int J Oncol; 2001 Feb; 18(2):331-6. PubMed ID: 11172600
[TBL] [Abstract][Full Text] [Related]
18. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects.
Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X
Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086
[TBL] [Abstract][Full Text] [Related]
19. Redox-sensitive lipophilic prodrugs: delivering unstable chemotherapeutant for improved cancer therapy.
Li F; Huang Z; Chen H; Yan L; Li J; Su Y; Zhang Q; Huang Z; Zheng Y
Drug Deliv; 2019 Dec; 26(1):1068-1079. PubMed ID: 31735094
[TBL] [Abstract][Full Text] [Related]
20. Assessment of normal and tumor tissue uptake of MAG-CPT, a polymer-bound prodrug of camptothecin, in patients undergoing elective surgery for colorectal carcinoma.
Sarapa N; Britto MR; Speed W; Jannuzzo M; Breda M; James CA; Porro M; Rocchetti M; Wanders A; Mahteme H; Nygren P
Cancer Chemother Pharmacol; 2003 Nov; 52(5):424-30. PubMed ID: 12904897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
